(Q39645325)

13 September 2017

title

Preparation and characterization of intravenously injectable curcumin nanosuspension (English)

1 reference

13 September 2017

0 references

Yan Gao

1

1 reference

13 September 2017

Zhonggang Li

2

1 reference

13 September 2017

Min Sun

3

1 reference

13 September 2017

Chenyu Guo

4

1 reference

13 September 2017

Aihua Yu

5

1 reference

13 September 2017

Yanwei Xi

6

1 reference

13 September 2017

Jing Cui

7

1 reference

13 September 2017

Hongxiang Lou

8

1 reference

13 September 2017

Guangxi Zhai

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

12 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

131-142

1 reference

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Nanosizing--oral formulation development and biopharmaceutical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

A density-functional model for controlled release.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

In vitro and in vivo antitumor activity of oridonin nanosuspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Kinetic solubility and dissolution velocity of rutin nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Characterization of curcumin-PVP solid dispersion obtained by spray drying.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Nanosuspensions in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Pharmacokinetics and pharmacodynamics of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Loading of curcumin into macrophages using lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

Preparation and characterization of intravenously injectable nimodipine nanosuspension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.520353

10.3109/10717544.2010.520353

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference